Advertisement

Malignant peritoneal mesothelioma

  • Cai-Pu Chun
    Affiliations
    Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Chaoyang District, Beijing, PR China

    Department of Pathology, The Fourth Affiliated Hospital of Shihezi University, Akesu, Xinjiang, PR China.
    Search for articles by this author
  • Lin-Xie Song
    Affiliations
    Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Chaoyang District, Beijing, PR China
    Search for articles by this author
  • Hong-Pan Zhang
    Affiliations
    Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Chaoyang District, Beijing, PR China
    Search for articles by this author
  • Dan-Dan Guo
    Affiliations
    Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Chaoyang District, Beijing, PR China
    Search for articles by this author
  • Gui-Xuan Xu
    Affiliations
    Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Chaoyang District, Beijing, PR China
    Search for articles by this author
  • Ya Li
    Affiliations
    Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Chaoyang District, Beijing, PR China
    Search for articles by this author
  • Xin Xin
    Affiliations
    Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Chaoyang District, Beijing, PR China
    Search for articles by this author
  • Jiachen Cao
    Affiliations
    Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Chaoyang District, Beijing, PR China
    Search for articles by this author
  • Feng Li
    Correspondence
    Corresponding author. Feng Li, MD, Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, No.8 Gongti South Road, Chaoyang District, Beijing 100020, PR China
    Affiliations
    Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Chaoyang District, Beijing, PR China
    Search for articles by this author
Published:August 05, 2022DOI:https://doi.org/10.1016/j.amjms.2022.07.008

      Abstract

      Malignant peritoneal mesothelioma (MPM) is a rare, life-threatening malignant tumor. We present a report of a rare case of a 67-year-old male patient with MPM and severe abdominal pain, bloating, and bloody ascites as manifestations. The diagnosis was confirmed by cytology of ascites aspiration fluid and further verified by laparoscopic exploratory biopsy. The characteristics of signs and clinical manifestations in this case are less common. As everyone knows, asbestos exposure is usually associated with pleural mesothelioma, but only 6%–10% of malignant mesothelioma cases originate from the peritoneum, which is far less than pleural mesothelioma. Generally, its non-specificity provides a huge challenge to medical professionals in its diagnosis, and this is also the main reason for delayed diagnosis. Patients should be vigilant, even though no clear risk factor is observed.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Greenbaum A.
        • Alexander H.R.
        Peritoneal mesothelioma.
        Transl Lung Cancer Res. 2020; 9: S120-S132https://doi.org/10.21037/tlcr.2019.12.15
        • Noiret B.
        • Renaud F.
        • Piessen G.
        • et al.
        Multicystic peritoneal mesothelioma: a systematic review of the literature.
        Pleura Peritoneum. 2019; 4 (Published 2019 Sep 25)20190024https://doi.org/10.1515/pp-2019-0024
        • Alexander H.R.
        • Burke A.P.
        Diagnosis and management of patients with malignant peritoneal mesothelioma.
        J Gastrointest Oncol. 2016; 7: 79-86https://doi.org/10.3978/j.issn.2078-6891.2015.134
        • Li C.Y.
        • Alexander H.R.
        Peritoneal metastases from malignant mesothelioma.
        Surg Oncol Clin N Am. 2018; 27: 539-549https://doi.org/10.1016/j.soc.2018.02.010
        • Broeckx G.
        • Pauwels P.
        Malignant peritoneal mesothelioma: a review.
        Transl Lung Cancer Res. 2018; 7: 537-542https://doi.org/10.21037/tlcr.2018.10.04
        • Carbone M.
        • Adusumilli P.S.
        • Alexander H.R.
        • et al.
        Mesothelioma: scientific clues for prevention, diagnosis, and therapy [published correction appears in CA Cancer J Clin. 2020 Jul;70(4):313-314].
        CA Cancer J Clin. 2019; 69: 402-429https://doi.org/10.3322/caac.21572
        • Ibrahim A.M.
        • Al-Akchar M.
        • Obaidi Z.
        • et al.
        Malignant peritoneal mesothelioma: a rare cause of ascites.
        J Investig Med High Impact Case Rep. 2018; 6 (Published 2018 Oct 16)2324709618807506https://doi.org/10.1177/2324709618807506
        • Baker P.M.
        • Clement P.B.
        • Young R.H.
        Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis.
        Am J Clin Pathol. 2005; 123: 724-737https://doi.org/10.1309/2h0n-vrer-pp2l-jdua
        • Kim J.
        • Bhagwandin S.
        • Labow D.M.
        Malignant peritoneal mesothelioma: a review.
        Ann Transl Med. 2017; 5: 236https://doi.org/10.21037/atm.2017.03.96
        • Joseph N.M.
        • Chen Y.Y.
        • Nasr A.
        • et al.
        Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.
        Mod Pathol. 2017; 30: 246-254https://doi.org/10.1038/modpathol.2016.188
        • Desmeules P.
        • Joubert P.
        • Zhang L.
        • et al.
        A subset of malignant mesotheliomas in young adults are associated with recurrent EWSR1/FUS-ATF1 fusions.
        Am J Surg Pathol. 2017; 41: 980-988https://doi.org/10.1097/PAS.0000000000000864
        • Rodríguez D.
        • Cheung M.C.
        • Housri N.
        • et al.
        Malignant abdominal mesothelioma: defining the role of surgery.
        J Surg Oncol. 2009; 99: 51-57https://doi.org/10.1002/jso.21167
        • Park J.Y.
        • Kim K.W.
        • Kwon H.J.
        • et al.
        Peritoneal mesotheliomas: clinicopathologic features, CT findings, and differential diagnosis.
        AJR Am J Roentgenol. 2008; 191: 814-825https://doi.org/10.2214/AJR.07.3628
        • Low R.N.
        • Barone R.M.
        Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures.
        Ann Surg Oncol. 2012; 19: 1394-1401https://doi.org/10.1245/s10434-012-2236-3
        • Beebe-Dimmer J.L.
        • Fryzek J.P.
        • Yee C.L.
        • et al.
        Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-medicare investigation of treatment patterns and overall survival.
        Clin Epidemiol. 2016; 8 (Published 2016 Oct 26): 743-750https://doi.org/10.2147/CLEP.S105396
        • Kobayashi M.
        • Moriwaki T.
        • Ochi D.
        • et al.
        A case of malignant peritoneal mesothelioma with the epithelioid histological type, successfully treated with pemetrexed plus cisplatin.
        Gan To Kagaku Ryoho. 2014; 41: 361-364